• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • Events By OncoDaily
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Immune Oncology
  • Breast Oncology
  • Gastrointestinal Oncology
  • Lung Oncology
  • Hematology
  • Radiotherapy
  • Cancer Types
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Services
  • Privacy Policy
  • Contact Us
Double Left Left Aug / 2026 Right Double Right
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
« Jul    
OncodailyJournal CancerWorld
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • Events By OncoDaily
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma

Geriatric Oncology in Brazil: Overcoming The Barriers to High-Quality Cancer Care For Older Adults

100 Influential People in Oncology 2026 – Nominations are Open!

Benny Johnson: Excited to Join Bristol Myers Squibb as Executive Director, Late-Stage Oncology for GI Cancers

Danny Burke: Study Identifying 272 Ongoing Cancer Clinical Trials in Brazil

CheckMate 77T: ctDNA Clearance and MRD Refine Risk After Perioperative Nivolumab

TP53-Mutated MDS: Can New Therapies Change the Prognosis?

TRUMPET Registry: mCRPC Treatment and Outcomes by Race, Initial Diagnosis, and Family History

OncoCalendar

1 event found.

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

« All Events
Phone +61 2 9054 3600
Email anzup@anzup.org.au
Website https://anzup.org.au/

Events from this organizer

Today
  • June 2026

  • Sun 28
    ANZUP 2026

    ANZUP 2026 Annual Scientific Meeting

    Jun 28 - Jun 30
    Adelaide Convention Centre North Terrace, Adelaide, South Australia, Australia

    The ANZUP 2026 Annual Scientific Meeting is the premier genitourinary (GU) cancer meeting in the region, bringing together clinical researchers, healthcare professionals, and consumer advocates. Scheduled for June 28–30, 2026, in Adelaide, the meeting serves as a critical platform for presenting the latest data on prostate, kidney, bladder, and testicular cancers. The technical program features […]

  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer Breast Cancer cancer care ASCO fight against cancer Lung cancer Global fight against cancer Cancer research Headlines immunotherapy ESMO NSCLC cancer treatment MD Anderson Cancer Center cancer awareness clinical trials colorectal cancer Research prostate cancer FDA Childhood Cancer UICC AACR ASCO24 chemotherapy Dana-Farber Cancer Institute radiation oncology Pancreatic Cancer American Cancer Society Robert Orlowski American Society of Clinical Oncology SIOP European Cancer Organisation AI NCI Myeloma Paper of the Day National Cancer Institute Paolo Tarantino WHO cervical cancer Vivek Subbiah Precision Oncology Myeloma radiotherapy IASLC bladder cancer multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}